Jim Simons’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,337,533
| Closed | -$51.3M | – | 3345 |
|
|
2025
Q4 | $51.3M | Buy |
3,337,533
+198,986
| +6% | +$2.19M | 0.08% | 288 |
|
|
2025
Q3 | $31.2M | Buy |
3,138,547
+252,018
| +9% | +$2.62M | 0.04% | 534 |
|
|
2025
Q2 | $28.6M | Buy |
2,886,529
+181,000
| +7% | +$1.91M | 0.04% | 560 |
|
|
2025
Q1 | $35.1M | Buy |
2,705,529
+350,251
| +15% | +$4.63M | 0.05% | 435 |
|
|
2024
Q4 | $30.1M | Buy |
2,355,278
+41,000
| +2% | +$496K | 0.04% | 488 |
|
|
2024
Q3 | $25.8M | Sell |
2,314,278
-163,900
| -7% | -$1.81M | 0.04% | 553 |
|
|
2024
Q2 | $27.8M | Buy |
2,478,178
+53,600
| +2% | +$624K | 0.05% | 469 |
|
|
2024
Q1 | $30.1M | Buy |
2,424,578
+486,500
| +25% | +$6.35M | 0.05% | 473 |
|
|
2023
Q4 | $27.1M | Buy |
1,938,078
+303,049
| +19% | +$4.21M | 0.04% | 494 |
|
|
2023
Q3 | $24.1M | Sell |
1,635,029
-341,703
| -17% | -$4.81M | 0.04% | 495 |
|
|
2023
Q2 | $25.5M | Sell |
1,976,732
-669,577
| -25% | -$7.63M | 0.04% | 561 |
|
|
2023
Q1 | $26M | Buy |
2,646,309
+1,035,658
| +64% | +$11.1M | 0.03% | 598 |
|
|
2022
Q4 | $17.1M | Buy |
1,610,651
+545,300
| +51% | +$6.34M | 0.02% | 799 |
|
|
2022
Q3 | $11.1M | Sell |
1,065,351
-185,500
| -15% | -$2.42M | 0.02% | 979 |
|
|
2022
Q2 | $15.7M | Buy |
1,250,851
+629,200
| +101% | +$6.68M | 0.02% | 857 |
|
|
2022
Q1 | $6.74M | Buy |
621,651
+374,100
| +151% | +$4.54M | 0.01% | 1385 |
|
|
2021
Q4 | $3.48M | Sell |
247,551
-217,554
| -47% | -$3.58M | ﹤0.01% | 1767 |
|
|
2021
Q3 | $8.94M | Buy |
+465,105
| New | +$6.18M | 0.01% | 1097 |
|
|
2019
Q3 | – | Sell |
-187,251
| Closed | -$747K | – | 3474 |
|
|
2019
Q2 | $747K | Buy |
+187,251
| New | +$1.09M | ﹤0.01% | 2833 |
|
|
2018
Q2 | – | Sell |
-228,919
| Closed | -$4.54M | – | 3312 |
|
|
2018
Q1 | $4.54M | Buy |
228,919
+146,868
| +179% | +$2.54M | 0.01% | 1879 |
|
|
2017
Q4 | $1.53M | Sell |
82,051
-7,500
| -8% | -$151K | ﹤0.01% | 2481 |
|
|
2017
Q3 | $1.93M | Buy |
+89,551
| New | +$1.42M | ﹤0.01% | 2312 |
|
|
2017
Q2 | – | Sell |
-574,051
| Closed | -$3.42M | – | 3223 |
|
|
2017
Q1 | $3.42M | Buy |
574,051
+110,100
| +24% | +$529K | ﹤0.01% | 1936 |
|
|
2016
Q4 | $1.83M | Buy |
+463,951
| New | +$3.4M | ﹤0.01% | 2270 |
|
|
2016
Q1 | – | Sell |
-174,473
| Closed | -$4.21M | – | 3403 |
|
|
2015
Q4 | $4.21M | Sell |
174,473
-128,078
| -42% | -$3.21M | 0.01% | 1615 |
|
|
2015
Q3 | $7.42M | Buy |
302,551
+276,300
| +1,053% | +$7.82M | 0.02% | 1115 |
|
|
2015
Q2 | $615K | Sell |
26,251
-32,800
| -56% | -$714K | ﹤0.01% | 2656 |
|
|
2015
Q1 | $1.32M | Buy |
+59,051
| New | +$1.13M | ﹤0.01% | 2160 |
|
|
2014
Q4 | – | Sell |
-13,169
| Closed | -$188K | – | 2996 |
|
|
2014
Q3 | $188K | Sell |
13,169
-100,760
| -88% | -$1.45M | ﹤0.01% | 2565 |
|
|
2014
Q2 | $1.82M | Buy |
+113,929
| New | +$1.72M | ﹤0.01% | 1777 |
|
|
2014
Q1 | – | Sell |
-156,251
| Closed | -$3.06M | – | 2879 |
|
|
2013
Q4 | $3.06M | Buy |
156,251
+120,715
| +340% | +$1.77M | 0.01% | 1498 |
|
|
2013
Q3 | $423K | Buy |
+35,536
| New | +$447K | ﹤0.01% | 2355 |
|
Other funds holding DVAX
Jim Simons's DVAX Position: Q1 2026 in Review
Jim Simons sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 3,337,533 shares — an estimated $51.3M sold.
Jim Simons first reported a position in DVAX in Q3 2013 and held it in 32 quarters. The position peaked at $51.3M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Jim Simons reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Jim Simons sold 3,337,533 Dynavax Technologies shares in Q1 2026, an estimated $51.3M.
- Jim Simons first reported a position in Dynavax Technologies in Q3 2013 and held it in 32 quarters.
- Jim Simons's Dynavax Technologies position peaked at $51.3M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.